Clinical trial
Evaluating the Utility of Urinary Proteomics and Novel Biomarkers in Acute Kidney Injury
NCT01573104 is registered in ClinicalTrials.gov with Dr Robert Docking as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Utility of Urinary Proteomics and Novel Biomarkers in Acute Kidney Injury
- Lead sponsor
- Dr Robert Docking
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- January 31, 2015
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.